Antonio Oliver

69PUBLICATIONS
113CO-AUTHORS
Medical infection agents (incl. prions)Medical bacteriologyMicrobial geneticsGenomics and transcriptomicsGenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (69)

|Sep 16, 2026
In vivo efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa carrying the AmpC E219K substitution.

|Aug 19, 2026
In vivo emergence of ceftazidime/avibactam resistance in Pseudomonas aeruginosa driven by OXA-1381, a novel W157L Ω-loop variant of OXA-2.

|Aug 19, 2026
Comparison of Galleria mellonella, epithelial cell cytotoxicity, and mouse model of bacteremia to measure Pseudomonas aeruginosa virulence.

|Jun 15, 2026
Characterizing the V516M penicillin-binding protein 2 (PBP2) mutation causing zidebactam resistance in Pseudomonas aeruginosa.

|May 29, 2026
Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa.

|Mar 27, 2026
Emergence of KPC-producing Pseudomonas aeruginosa in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam.

Gloria Pérez-Rodríguez, Pablo Aja-Macaya, Lucía González-Pinto

Pageof 12

Frequent Collaborators

14 joint publications

Gabriel Cabot

9 joint publications

Jorge Arca-Suárez

8 joint publications

Germán Bou

8 joint publications

Lucía González-Pinto